Russia Viscosupplementation Market is expected to reach RUB 2.02 billion (US$ 34 million) by the end of 2026

Russia’s healthcare infrastructure will continue witnessing significant rise in number of orthopaedic patients as several bone & joint-related disorders are likely to be caused by people’s eating & drink habits, their proactive lifestyles and the country’s harsh weather conditions. Rising occurrence of joint-related ailments such as knee osteoarthritis in Russia are a result of people performing physical labour in severely cold weather conditions. This has necessitated the adoption of viscosupplementation as an ideal medical procedure for injecting lubricating fluid in bone joints during surgeries. An in-depth analysis of Russia’s viscosupplementation market, conducted by Future Market Insights, projects that demand for three-injection viscosupplementation will gain traction over the next decade.

According to Future Market Insights’ recent report, titled “Viscosupplementation Market: Russia Industry Analysis and Opportunity Assessment, 2016-2026,” nearly 70% of viscosupplementation revenues amassed across Russia in 2016 were accounted by three-injection viscosupplementation. The report estimates that the Russian viscosupplementation market incurred revenues worth over RUB 1.13 billion (US$ 19 million) in 2016. Registering a steady increment at 5.8% CAGR, Russia’s viscosupplementation revenues are expected to reach RUB 2.02 billion (US$ 34 million) by the end of 2026. With higher demand for three-injection viscosupplementation, Russia’s healthcare industry leaders will continue to extend production of three-injection viscosupplementation products as opposed to single injection and five-injection viscosupplementation products.

The report also establishes projections regarding the end-use of viscosupplementation in Russia. Hospitals across the country will account for just above RUB 1.24 billion (US$ 21 million) revenues by the end of projection period. Within this, the demand for viscosupplementation will remain considerably higher in hospitals with capacity of more than 500 beds. End-use of viscosupplementation in Russia’s ambulatory surgical centres (ASCs) will remain nascent, while revenues accounted by orthopaedic clinics are expected to surpass RUB 595 million (US$ 10 million) through 2026.

Top Players in Russia’s Viscosupplementation Market

Top three established players in Russia’s Viscosupplementation market include Hyaltech, Croma-Pharma GmbH and TRB Chemedica. The market is fragmented with small players holding substantial market share. While Hyaltech, Croma-Pharma GmbH and TRB Chemedica collectively dominate with more than half of the country’s viscosupplementation revenues. International players such as Sanofi, Ferring Pharmaceuticals and Fidia Farmaceutici spa have low share as compared to the other players, Anika Therapeutics has recently launched their viscosupplementation product in Russia’s viscosupplementation market.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-2897

The market is divided into two segments based on product type and end use:By Product Type

  • Single Injection Viscosupplementation
  • Three Injection Viscosupplementation
  • Five Injection Viscosupplementation

By End Use

  • Hospitals
    • 500+ Bedded
    • 250-500 Bedded
    • Less Than 250 Bedded
  •  Ambulatory Surgical Centres
  • Orthopaedic Clinics

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-2897

Middle East Veterinary Vaccines Market reflects a cumulative CAGR of around 4.8% over the forecast period (2021-2031)

[192 Pages Report] According to a recent study by Future Market Insights (FMI), the Middle East Veterinary Vaccines Market is expected to witness moderate growth during the forecast period. The market is expected to grow from US$ 335.0 Mn in 2021 to over US$ 533.4 Mn by 2031. This reflects a cumulative CAGR of around 4.8% over the forecast period (2021-2031).

The demand for veterinary vaccines has increased over the past few years due to the increasing incidences of foodborne and zoonotic infections amongst the population in the Middle Eastern region. The pattern of veterinary treatment is shifting from curative/reactive to preventive in these countries. The cost of preventive treatment is much smaller and has far fewer side effects than reactive treatments that often lead to mass slaughter.

The rebound of economic prosperity in MEA markets is expected to contribute towards increased demand for processed healthy meat products. This will fuel the demand for effective vaccination of livestock, especially in major animal farming and meat-producing nations in the region with a diversified herd such as Sudan, Turkey, Egypt and KSA.

Rising per capita disposable income levels are largely contributing towards demand for processed food items. This is expected to drive the growth of veterinary vaccines in poultry and livestock segments.

The key players of the veterinary vaccines industry are focusing on finding innovative products to control zoonotic infection rates. Along with this, various advancements in biotechnology are expected to create a favourable platform for the development of various veterinary vaccines in developing markets such as UAE, KSA, Turkey and Jordan. These techniques include next-generation sequencing, synthetic biology and systems biology, among others.

Further, continued investments in multi-disciplinary vaccinology research could improve vaccine development efficiency and shorten time-to-market for upcoming veterinary vaccines.

Key players are working on innovative products, conducting acquisitions, mergers, agreements with other companies to improve their market presence and tap into less competitive emerging markets.

For instance, In September 2018, Boehringer Ingelheim announced that they would be donating 75,000 doses of rabies vaccines to the Global Alliance for the Rabies Control, as an effort of recognition of World Rabies Day on September 28th.

Such developments not only strengthen the company’s existing portfolio but also help to increase their presence at the regional as well as global level, and help companies to sustain the increasing competitive pressure.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-3086

Key Takeaways from Middle East Veterinary Vaccines Study

  • The attenuated live vaccines accounted for 35.1% share of the total market of veterinary vaccines in the Middle East in 2021. The demand for attenuated live vaccines is expected to grow at a CAGR of 5.8% over the forecast period. By triggering a wide spectrum of immune responses, attenuated vaccines can deliver better immunity than conventional vaccinations.
  • The livestock animals held the maximum share of 73.9% of the total veterinary vaccines market in terms of animal in 2021. Increased demand for processed meat products and making animal health a critical component of disease control is leading to increasing adoption of livestock animal’s vaccination in the Middle Eastern region.
  • The foot and mouth disease accounted for more than 27% of the market share of the Middle East veterinary vaccines market in 2021. Foot and mouth disease is the most commonly occurring disease amongst all the animals. This segment is expected to project a cumulative CAGR of 5.6% over the forecast period.
  • The private veterinary pharmacies registered sales worth U.S. $ 114.6 Mn during the year 2021 and are expected to project a cumulative CAGR of 5.0% over the forecast period. Increased awareness regarding animal vaccinations, rising incidences of foot and mouth disease and high demand for good quality processed meat are some of the factors contributing to the growth of private veterinary pharmacies in the Middle East.

Who is winning?The key manufacturers of the veterinary vaccines market are adopting strategies such as partnership strategies for global expansion and improving their hold over the global market.

  • In January 2021, Merck Animal Health announced the acquisition of Poultry Sense Ltd, which provides health and environmental monitoring solutions for the poultry industry.
  • In September 2019, Ceva, in partnership with Biotecon diagnostics, announced the launch of their latest product, a real-time diagnostic kit that will help the poultry producers to fight salmonella infections in their farms.

The key market players of the Middle East veterinary vaccines market include JOVA, Bioveta, Inc., Intervac Pvt. Ltd., Zoetis, Elanco, Merial, Merck & Co. Inc, Bayer Pharma AG, Ceva and Boehringer Ingelheim.

Middle East Veterinary Vaccines, by CategoryVaccine:

  • Attenuated Live Vaccines
  • Inactivated Vaccines
  • Toxoid Vaccines
  • DNA Vaccines
  • Recombinant Vaccines
  • Others

Animal:

  • Companion Animals
    • Canine
    • Avian
    • Feline
  • Livestock Animals
    • Aquatic
    • Bovine
    • Porcine
    • Small Ruminant
    • Poultry
  • Equine

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-3086

Disease Indication:

  • Foot and Mouth Disease
  • Newcastle Disease
  • PPRS
  • Canine Parvovirus
  • Brucellosis
  • Avian Influenza
  • Others

End-User

  • Hospital Pharmacies
  • Veterinary Clinics
  • Private Veterinary Pharmacies
  • Others

Fish Protein Concentrate Market Size By Key Players, Competition Tracking, Applications & Forecast 2031

Increasing awareness regarding health and wellness among consumers, their focus towards the adoption of fitness goals, rising demand of fish protein concentrate in cosmetics, personal care segment, pharmaceuticals are key factors enabling growth in the fish protein concentrate market. Future Market Insights (FMI) predicts positive near-term growth for the market in a new study. According to the report, the market will reach US$ 107.7 Mn in 2021.

Increasing frequency of product launches and the demand for greater sustainability and clean label certifications are creating lucrative growth opportunities for the fish protein concentrate market. These proteins are gradually increasing in demand in the food industry as ingredients often used as meat substitute and on account of their fat-binding properties.

Fish is a low-fat high quality source of protein and a great source of vitamins, minerals, and omega 3 fatty acids. Its consumption therefore associated with good heart and brain function, combating inflammation in joints and providing lubrication to joints. Fish protein concentrates have therefore found their way into the food & beverages industry, which currently accounts for the leading share in the market among end users.

Request a report sample to gain comprehensive market insights @

https://www.futuremarketinsights.com/reports/sample/rep-gb-8037

RFID Tags Increasingly Preferred for Fish Protein Concentrate Packaging

Adoption of RFID technology is increasing since manufactures are seeking an efficient supply chain algorithm, where they could keep a track of their products thus save overall time of transportation and ensure product availability. Fish protein concentrate manufactures also are facing similar issues, which have been tipping scales in favour of RFID labels in the market.

RFID hides away data up to 2 KB identified with the item on which it is labelled. The costs and subtleties of the items with RFID labels are consequently recorded when the client moves toward the counter, without filtering each any item, which saves the hour of the client. In addition, it permits cost count in one sweep, which saves the hour of the client just as the item retailer.

These factors would impact fish protein concentrate market and would give a chance to have a development in products and ventures. Adoption of latest technologies is expected to bode well for the overall market.

Key Takeaways from Fish Protein Concentrates Market Study

  • Fish protein concentrate market is forecast to register 6.3% Y-o-Y growth in 2021
  • The U.S. will account for a significant share of sales in North America. FMI has projected the U.S. to nearly 93% of the North America market, in terms of value, in 2021
  • Within the U.K. the market for fish protein concentrate will exhibit slightly over 4% Y-o-Y growth in 2021
  • France and Germany will emerge as other key markets in Europe, exhibiting high demand for fish protein concentrate
  • Within East Asia, Japan and South Korea will emerge as highly lucrative markets for fish protein concentrate

Increasing number of fish protein manufacturers are focusing on research and development to push product launches. Besides this, there is considerably focus on expanding footprint across emerging countries to gain competitive advantage” said a lead analyst at FMI

Who is winning?                                                             

Some of the key players operating in fish protein Market are Janatha Fish Meal & Oil Products, Bevenovo Co. Ltd, Bio-Oregon Protein, Omega Protein Corporation, Colpex International Inc., Shenzhen Taier Biotechnology Co. Ltd., New Alliance Dye Chem Pvt. Ltd., Peterlabs Holdings, Mukka Seafood Industries Limited, Scanbio Marine Group, Apelsa Guadalajara, Siam Industries International, and other.

Key players of Fish protein Concentrate are focusing on partnership in order to gain larger market share and to capture new geographical areas to get access to new markets.

  • Another recent development in 2018, by Omega Proteins a leading manufacturer was that the company launched Vermilion, a fishing vessel.
  • In 2020, Paine and partners, LLC, announced that it has signed a deal to purchase, Scanbio Marine group.

Contact Sales for Further Assistance in Purchasing this Report@ https://www.futuremarketinsights.com/checkout/8037

Get Valuable Insights into Fish Protein Concentrate Market

Future Market Insights, in its new report, presents an unbiased analysis of the global plant-based Collagen market, covering historical demand data and forecast figures for the period Based on

By Form

  • Powder
  • Liquid

By Type

  • Type A
  • Type B
  • Type C

By End Use

  • Food & Beverages
  • Sport Nutrition & Dietary Supplement
  • Cosmetic & Personal Care
  • Pharmaceuticals
  • Others

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Middle East and Africa (MEA)
  • Oceania

About Food Market Division at FMI

Expert analysis, actionable insights, and strategic recommendations – the food & beverage team at Future Market Insights helps clients from across the globe with their unique business intelligence needs. With a repertoire of over 1,000 reports and 1 million+ data points, the team has analysed the food & beverage industry lucidly in 50+ countries for over a decade. The team provides end-to-end research and consulting services; reach out to explore how we can help.

Taurine Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2021-2031

Future Market Insights (FMI), in a new study has forecast the demand for taurine to surge considerably in the coming years. Driven by diverse end-use applications, the global taurine market is set to reach US$ 364.4 Mn by 2021. Growth forecasts continue to remain strong, thanks to rising focus on health and wellness. The market will witness impressive growth opportunities through the forecast period, especially as application continues to surge in beverage sector.

Taurine is increasingly used in various health drinks and energy drinks. FMI has forecast, the beverage segment to account for lion’s share of the global market through the forecast period. Taurine an essential amino acid is structurally as well as functionally for the body. Taurine plays a crucial role in human beings, pet, as well as fish. This is owing to the reason that taurine has such wide and essential applications.

In the European Union and China, taurine is considered essential in fish feed and is also authorized to be used for all species of fishes. There are rising speculations of replacing meat and marine-based products from the fish feed with alternate protein sources. Plant-based protein for instance soybean meal with taurine makes an excellent meal for fish, comprising of all essential nutrients required.

Request a report sample to gain comprehensive market insights @

https://www.futuremarketinsights.com/reports/sample/rep-gb-2746

Key Takeaways from the Taurine Market Study

  • Taurine market will continue showcasing solid growth through forecast period. It is projected to record 6.9% Y-o-Y growth in 2021
  • The U.S. will continue exhibiting high demand and account for dominant 82.6% of the North America market
  • Growth in the U.K. to remain positive as the country is forecast to exhibit 4% Y-o-Y growth in 2021
  • France and Germany will emerge as lucrative pocket for taurine sales in Europe
  • While growth rate in Japan and South Korea will remain positive, China is expected to account for leading market share through forecast period

“Surging demand for cosmetic products and health care products has a great impact on the taurine market. Manufacturers of taurine are intensively researching for enhancing production process of taurine to serve the large market which has further potential to grow.”

Alternate Source of Taurine in Development

The increasing vegan population has bolstered the need for an alternate source of taurine, either plant-based or synthetic process. A large number of taurine manufacturers depend on the latter method for taurine production as chemical processes are easy to control and can alter production quantity as per requirement. The synthetic production process of taurine also requires less number of raw material, whereas natural sources such as algae need to be handled well for adequate production of taurine.

Taurine manufacturers are developing these innovative processes and patenting under their name to maintain their market position with high quality of taurine.

Taurine in Energy Drinks

Taurine is a crucial ingredients in energy drinks and is prominently used by key manufacturers such as Redbull, Monster Drink. Energy drinks claims to have several health benefits, owing to which millennials and gen-z are anticipated to gravitate towards these products and taurine will experience a cascading effect of increase in demand in the forecast period.

For Information On The Research Approach Used In The Report, Ask Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-2746

Scope of the Report

Attribute Details
Forecast Period 2021-2031
Historical Data Available for 2016-2020
Market Analysis USD Million for value and Metric Tons for Volume
Key Regions Covered North America, Latin America, Europe, East Asia, South Asia, Oceania Middle East & Africa
Key Countries Covered US, Canada, Brazil, Mexico, Chile, Peru, Argentina, Rest of Latin America, Germany, France, Italy, U.K., Spain, BENELUX, Nordic, Poland, Russia, Rest of Europe, China, Japan, South Korea, India, Malaysia, Singapore, Indonesia, Thailand, Rest of South Asia, Australia, New Zealand, GCC Countries, South Africa, Turkey, North Africa, Central Africa, Rest of MEA
Key Segments Covered End Use Application
Key Companies Profiled
  • MTC Industries Inc.
  • Stauber USA.
  • Foodchem International Corporation
  • The Honjo Chemical Corporation
  • Qianjiang Yongan Pharmaceutical Co., Ltd.
  • New Zealand Pharmaceuticals Ltd.
  • Ajinomoto Co., Inc.
  • Kyowa Hakko Bio Co., Ltd.
  • Jiangsu Yuanyang Chemical Co., Ltd.
  • Fuchi Pharmaceutical Co., Ltd
  • Penta Manufacturing Company
  • Mitsui Chemicals, Inc.
  • AuNutra Industries Inc.
  • Hebi City Hexin Chem Ind. Co., Ltd.
Report Coverage Market Forecast, brand share analysis, competition intelligence, DROT analysis, Market Dynamics and Challenges, Strategic Growth Initiatives
Customization & Pricing Available upon Request

Several leading manufacturers of taurine are focusing on strengthening production capacity and distribution channels to expand their footprint in the global market. Leading players also are investing in research and development to produce organic, non-GMO ingredients for Taurine and to develop a novel production process that will also be suitable for consumption by vegan and flexitarian.

Manufacturers are also seen capitalizing on the opportunity in the food processing industry. Taurine is known to act as an emulsifier and flavoring agent in many processed food. Manufacturers are producing baby food formula with taurine as an ingredients that are targeted for neonatal who are born under-weight or premature.

  • In August 2019, Foodchem International Corporation commenced the expansion project in Jiangxi Province, China owing to the rising demand of taurine.
  • Qianjiang Yongan Pharmaceutical Co., Ltd., is further planning to expand its production capacity of taurine. For supporting this aim, the company has started strengthening its distribution network by opening warehouses and storage capacity.

Get Valuable Insights into Taurine fiber Market

Future Market Insights, in its new offering, provides an unbiased analysis of the Taurine market, presenting historical demand data (2016-2020) and forecast statistics for the period from 2021-2031. The study divulges compelling insights on the Taurine market based on End Use Application (Food, Beverage, Animal Feed, Pet Food, Pet Supplements, Dietary Supplements, Cosmetics & Personal Care Products, Agriculture, and Pharmaceuticals), across seven major regions.

Sodium Malate Market is expected to observe a CAGR of 4% over 2022-2032 | FMI

Newly released data from Sodium Malate Market Analysis by Future Market Insights show that the global market size of Sodium malate is expected to reach USD 715 Million by 2032. The market is growing at a CAGR of 4% during the forecasted year 2022-2032.

“The market for sodium malate is booming, in parallel with the ever-changing consumer food habits. The increasing tendency to consume more and more processed food and decreasing trend of cooking a meal at home is increasing the demand for food additives and driving the global sodium malate market growth.” says FMI report.

Request a report sample to gain comprehensive market insights @

https://www.futuremarketinsights.com/reports/sample/rep-gb-9853

According to FAOSTAT data, the food and beverages industry generated approximately US$ 12.5 trillion of revenue, which summed up to 17% of world GDP, in 2013. Sodium malate is a sodium salt of malic acid and is used extensively in the food and beverages industry. Sodium malate is used predominantly as a food additive in food products such as bakery and confectionery, desserts, flavoured and soft drinks, meat products, etc. Sodium malate in the food and beverages industry functions as a flavouring agent, acidity regulator, and buffering agent.

Sales Continue to Benefit from Staggering Growth in Processed Food Products Sales

The food and beverages industry is flourishing, owing to the increased consumption of confectioneries and similar processed food products. With the advent of industrialization and increasing population, significantly in Asian countries, the bakery and confectionery industry is rapidly expanding in the region. This is increasing the demand for food additives and thus, driving the global market of sodium malate. According to the report, the food and beverage industry is expected to remain strong over the forecast period of 2019-2027.

According to the report, the increasing demand for cosmetics and personal care products is creating positive outlook in the global sodium malate market. Cosmetics and personal care industry is expected to account for ~30% of the market share by value. Sodium malate is used as a cosmetic additive, functioning as a skin conditioning agent and humectant. Sodium malate is also being used in the formulation of anti-aging, as well as lightening and whitening agents. Moreover, sodium malate is currently being researched for use as a pH adjuster in low concentration. The cosmetic industry has expanded and evolved rapidly over the last decade and is one of the major industries with high potential, which also brings promising potential for sodium malate. The cosmetic industry is well-established in developed markets such as North America, Europe, and Oceania, and is growing in other markets such as Asia and Middle East & Africa, presenting increased opportunity for sodium malate. Especially in developing nations such as India, Brazil, China, etc. the percentage of middle-class population is increasing at a rapid rate and increase in the income of middle-class population is observed. This increased demand for cosmetics and personal care products is expected to create promising market potential in the global sodium malate market.

For Information On The Research Approach Used In The Report, Ask Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-9853

Flourishing F&B Sectors to Bolster Sodium Malate Demand for Processed Foods

The research analysis by FMI reveals that the sodium malate market has promising future and increased opportunity in the developing countries. According to UN data of 2018, more than half of the world population is residing in urban areas and is projected to add 2.5 Bn by 2050, which will be approximately 68% of the total world population. Out of this additional 2.5 Bn urban population, 90% will be contributed by Asia and Africa, owing to the high growth rate of the population.

Major industry players of food and beverages, cosmetics, and pharmaceutical industries are entering these low urbanized regions, eyeing the availability of workforce and ease of business. With an increase in urbanization and industrialization, accessibility of consumer goods such as bakery, confectionery, soft drinks, cosmetics, and personal care products is improving in developing nations, ultimately increasing the consumption of these products. Sodium malate used as a food additive, has increasing opportunities in developing nations.

According to the report, use of sodium malate in the animal feed industry is likely to drive the global market insignificantly. Sodium malate is available in feed and/or fodder grade in the industry. Sodium malate is used as a feed ingredient for technological purposes and is being researched for use in new products. Sodium malate is also used as an acidity regulator and flavouring agent for feed products. The increasing population is also resulting in increasing meat consumption, and in order to increase meat production, animal feed is supplemented with various feed ingredients.

Market Segments Covered in Sodium Malate Industry Analysis

Type

  • Monosodium Malate
  • Disodium Malate

Application

  • Food and Beverages
  • Personal Care
  • Cosmetics
  • Animal Feed

Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific Excluding Japan
  • Middle East & Africa (MEA)
  • Oceania
  • Japan

Dental Caries and Endodontic Market is expected to exhibit 6.7% CAGR in the market through 2027

Farm Animal Drugs Market is anticipated to grow at nearly 9% CAGR through 2027

According to a latest study by Future Market Insights (FMI), the global farm animal drug market is projected to grow at over 6% CAGR during the period 2017-2027. Increased production of anti-infectives and penetration of parasiticides production in Latin America is expected to offer growth opportunities to players in this market.

The market will continue to be influenced by a slew of macro- and micro-economic factors. Demand for contamination-free meat and proteins and alliances between producers and meat companies will continue to offer growth opportunities.

North America Farm Animal Drugs Market

In North America, the U.S. will continue to be account for the leading revenue share. In 2017, the revenue share of the U.S. is anticipated to reach 58%; however, during the forecast period, it will lose slight market share to Canada. Demand for farm animal drugs in North America will continue to be influenced by growing consumption of fresh meat and regulation by the FDA to limit use of antibiotics on farm animals. FMI projects the North America farm animal drugs market to grow at 7% CAGR during the forecast period 2017-2027.

By product type, anti-infective drugs and parasiticides (endo-parasiticides, ecto-parasiticides, and endectocides). Anti-infectives are not only the largest but also the fastest-growing segment product type segment. By 2027, the anti-infective product type segment is projected to grow at nearly 9% CAGR. By animal type, poultry is the largest segment in North America, whereas ruminants and swine hold significant revenue share.

FMI also offers market forecast and analysis on the basis of route of administration. The oral route of administering drugs remains the most prominent in North America, with revenues projected to grow at over 7% CAGR. The parenteral drug segment, on the other hand, is anticipated to grow at nearly 9% CAGR through 2027.

By distribution channel, veterinary hospitals are the largest segment in North America, accounting for nearly US$ 2 billion in revenues in 2017. This segment is projected to grow at nearly 8% through 2027.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-2402

Western Europe Farm Animal Drugs Market

U.K. remains the largest market for farm animal drugs in Western Europe. The country accounts for over 40% revenue share of the market. FMI projects U.K. to remain the largest market for farm animal drugs in Western Europe throughout the forecast period. Germany and France are the other leading markets for farm animal drugs in Western Europe. Overall, the Western Europe farm animal drugs market is projected to reach US$ 2.83 billion revenues in 2027.

The key factors fuelling demand for farm animal drugs in Western Europe include focus on preventive measures against zoonotic diseases. Use of certain drugs for pain management is also a growing opportunity for manufacturers. As is the case in North America, the anti-infective product type segment is projected to grow at over 6% CAGR through 2027.

In addition to North America and Western Europe, the report also offers market forecast and analysis on Asia Pacific excluding Japan, Middle East & Africa, Latin America, and Japan.

Competitive Landscape

Key companies profiled in the report are Bayer AG, Boehringer Ingelheim GmbH, Zoetis, Inc.,  Ceva Santé Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health (Sub. Eli Lilly), Merck Animal Health, Virbac SA, Vetoquinol SA, Intas Animal Health, Alembic Animal Health, Sequent Scientific, Hester Biosciences, Ashish Life Sciences,  Ouro Fino Saude Animal (Ourofino), Zydus Animal Health (Sub. Cadila Healthcare Ltd), Phibro Animal Health Corporation,  Nippon Zenyaku Kogyo Co., Ltd, Norbrook, Kyoritsu Seiyaku Corporation.

Market segmentationA good market segmentation always covers the vitals in that particular market to arrive at important decisions. In the case of the farm animal drugs market, an all-inclusive research segmentation can be seen.

Product Type

  • Anti-Infective
  • Parasiticides
    • Endo-parasiticides
    • Ecto-parasiticides
    • Endectocides
  • Anti-inflammatory
  • Anesthetics
  • Analgesics
  • Hormones and related products
  • Others

Animal Type

  • Livestock Animals
    • Ruminants
    • Swine
    • Poultry
  • Equine

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-2402

Route of Administration

  • Oral
  • Parenteral
  • Topical
  • Others

Distribution Channel

  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies and Drug Stores
  • Others

Swine Respiratory Diseases Treatment Market is expected to reach a value of over US$ 2,700 Million in 2027 growing at a robust CAGR of 6.6% during the forecast period

Swine respiratory diseases treatment is carried out by drugs and vaccines that help in curing or preventing PRRS (porcine reproductive and respiratory syndrome), which is a most common respiratory disease in pigs. Drugs that are used for the treatment of swine respiratory diseases are given via various modes such as injections and in-feed inclusions. Vaccines are the biological preparation used to improve immunity for the disease. Vaccines that are used for swine respiratory diseases are basically of two types – live, attenuated vaccines and killed, inactivated vaccines.

A new research report by Future Market Insights gives an overview of the global swine respiratory diseases treatment market. The report is titled ‘Swine Respiratory Diseases Treatment Market: Global Industry Analysis 2012 – 2016 and Opportunity Assessment 2017 – 2027,’ which includes the analysis of the global as well as the regional markets. According to the report, the global swine respiratory diseases treatment market is expected to hold a market value of over US$ 1,430 Mn in 2017, which is expected to reach a value of over US$ 2,700 Mn in 2027 growing at a robust CAGR of 6.6% during the forecast period.

Global Swine Respiratory Diseases Treatment Market: Segmental Highlights

The market is segmented on the basis of causative agent, treatment type, route of administration, distribution channel and region.

  • By causative agent, Mycoplasma and Virus segments dominated the global swine respiratory diseases treatment market in revenue terms in 2016, and the trend is projected to continue throughout the forecast period.
  • By treatment type, drug segment is expected to be the most lucrative with its market size reaching a value of over US$ 1,700 Mn by the end of 2027. However, the vaccines segment is forecasted to witness a higher CAGR than drugs, with a growth rate of 7.2% during the forecast period.
  • By route of administration, the market is dominated by oral segment, which holds a market share of over US$ 1,200 Mn in 2017, growing at a CAGR of 6.6%. However, parental segment is ahead in terms of CAGR, growing at rate of 6.8% during the forecast period.
  • By distribution channel, the veterinary hospitals segment is expected to be the most lucrative among all routes of administration, forecasted to reach a market share of over US$ 990 Mn by the end of 2027. On the other hand pharmacies segment leads in terms of CAGR with a growth rate of 6.8% during 2017-2027.
  • By region, the APEJ regional market leads with its market value reaching over US$ 600 Mn in 2017. The second position is held by North America, which is anticipated to record a market size of over US$ 400 Mn in 2017.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-4342

Global Swine Respiratory Diseases Treatment Market: Dynamics

The market forecast for various segments is based on the factors that are impacting the global market. According to Future Market Insights analysis, the market is driven by an increase in the rate of diseases such as PRRS (Porcine reproductive and respiratory syndrome), the high demand of pork, and increase in the use of vaccines that are given to pigs in order to produce disease free pork.

However, there are a few factors prevailing in the market that may have a negative impact on the market such as stringent regulation by FDA to limit the use of antibiotics for farm animals and also lack of awareness in many countries where the pig farm owners are unaware of the diseases and treatment processes.

Global Swine Respiratory Diseases Treatment Market: Competitive Analysis

This comprehensive research report includes brief profiles of various major companies operating in the global market such as Zoetis, Bayer AG, Boehringer Ingelheim GmbH, Elanco Animal Health (Sub. Eli Lilly), Virbac, Norbrook, Ceva Santé Animale, Intervet Inc., (Sub. Merck & Co. Inc.), Vetoquin.

Segmentation of the Global Swine Respiratory Diseases Treatment Market

The segmentation of the global swine respiratory diseases treatment market helps readers simplify the market study and understanding, by dividing the market into different segments on the basis of various parameters. The report provides an individual analysis of each and every segment, thus covering every part of the market.

By Region

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • Japan
  • MEA

By Causative Agent

  • Virus
  • Mycoplasma
  • Bacteria
  • Others

By Treatment Type

  • Drugs
    • Antibiotic
    • Others
  • Vaccines

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-4342

By Route of Administration

  • Oral
  • Parenteral

By Distribution Channel

  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies
  • Others

Cranial Stabilisation Devices Market is projected to reach US$ 792.8 Million by the end of 2027

Future Market Insights has published a new report titled “Cranial Stabilisation Devices Market: Global Industry Analysis (2012 – 2016) and Opportunity Assessment (2017 – 2027)” that studies the overall performance of the global cranial stabilisation devices market for an assessment period of 10 years. The global cranial stabilisation devices market is anticipated to expand at a significant CAGR over the forecast period. Technological advancements in the field of neuroscience across the globe is a favourable factor boosting revenue growth of the global cranial stabilisation devices market. Revenue from the global cranial stabilisation devices market is expected to reach US$ 472.9 Mn by 2017 end and is projected to reach US$ 792.8 Mn by the end of 2027. Sales revenue is anticipated to register a robust CAGR of 5.3% between 2017 and 2027.

Global Cranial Stabilisation Devices Market: Key Trends

  • Steady growth in neurosurgical procedures across the globe
  • Increasing consolidations among key market players
  • Rising preference for branded products
  • Increasing awareness regarding regulatory concerns
  • Rapidly expanding healthcare facilities across the globe
  • Increasing spending on healthcare facilities across the world

Cranial Stabilization Devices Market: Macro Economic Factors

Over the last few years, government authorities in the Asia Pacific and the Middle East and Africa regions are encouraging start-up companies as well as MNCs to boost industrial growth in the healthcare and medical devices industry. Leading players in the medical devices market are capitalising on economies of scale to strengthen their position in the market. This is likely to have a positive impact on the global cranial stabilisation devices market.

Increasing incidence of life-threatening diseases due to changing lifestyles of people is creating a rise in demand for neurology procedures worldwide. It is expected that direct and indirect costs of treatment of neurological diseases and disorders will increase over a period of time. This is another factor likely to impact revenue growth of the global cranial stabilisation devices market.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-2537

Global Cranial Stabilisation Devices Market: Segmental Forecast

On the basis of product type, the global market for cranial stabilisation devices is segmented into Horseshoe Headrest, Skull Clamp System, and Brain Retractor System. Brain retractor system segment dominated the global cranial stabilisation devices market in revenue terms in 2016, and the trend is projected to continue throughout the forecast period. Brain retractor system segment is expected to be the most lucrative among all product types, with an attractiveness index of 1.6.

By end use the market is segmented into hospitals, ambulatory surgical centres and specialised centres. Specialized centres segment is expected to be the second largest market for cranial stabilisation devices, with a market share index of 0.7. Ambulatory surgical centres segment remains the third largest market with a market share index of 0.5.

Global Cranial Stabilisation Devices Market: Forecast by Region

Key geographies tracked in this report include North America, Latin America, Eastern Europe, Western Europe, APEJ, Japan and MEA. The APEJ cranial stabilisation devices market revenue is expected to expand at a significant CAGR over the forecast period. APEJ remains the third largest market due to increasing demand for cranial stabilisation devices such as horseshoe headrests, skull clamp systems and brain retractor systems. North America dominated the global cranial stabilisation devices market in revenue terms in 2016, and the trend is projected to continue throughout the forecast period. The North America cranial stabilisation devices market is expected to be the most lucrative among all regional markets, with an attractiveness index of 2.8.

Global Cranial Stabilisation Devices Market: Key Players

Micromar Ind. Com. Ltda, Pro Med Instruments, Inc., Integra LifeSciences Corporation, and Changzhou Huida Medical Equipment Co. Ltd. are some of the top companies operating in the global cranial stabilisation devices market.

Market TaxonomyBy Product Type

  • Horseshoe Headrest
  • Skull Clamp Systems
  • Brain Retractor System
  • Accessories

By End User

  • Hospitals
  • Ambulatory Surgical Centres
  • Specialised Centres

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-2537

Pressure Bandages Market is estimated to grow from US$ 186.5 Million in 2022 to US$ 257.4 Million by 2029

[195 Pages Report] According to a new report by Future Market Insights titled “Pressure Bandages Market: Global Industry Analysis (2014 – 2021) and Opportunity Assessment (2021 – 2029),” the global pressure bandages market is estimated to grow from US$ 186.5 Mn in 2022 to US$ 257.4 Mn by 2029 end. This reflects a CAGR of 3.3% over the forecast period 2022– 2029. The global market represents absolute $ opportunity of US$ 5.1 Mn in 2023 over 2022 and incremental opportunity of US$ 70.9 Mn between 2022 and 2029 North America is currently the most lucrative regional market for pressure bandages, followed by Western Europe and APEJ. However, in terms of annual growth, the Latin America pressure bandages market is anticipated to experience the highest CAGR of 3.9% during 2022-2029.

Global Pressure Bandages Market: Opportunities

  • Penetration of orthopaedic treatments in emerging economies including Asia Pacific and MEA is still not as widespread as compared to North America and Europe. This is owing to low awareness regarding advanced wound management and associated risk factors amongst the general as well as obese population
  • The retail e-commerce channel has gained significant attraction from consumers in the last few years, and is expected to show rapidly increasing adoption over the forecast period. Sales of pressure bandages through e-commerce have also increased in the last few years with e-commerce companies providing attractive discounts to their customers

Global Pressure Bandages Market: Forecast by Product TypeOn the basis of product type, the global market for pressure bandages is segmented into short stretch bandages, long stretch bandages and multi-layer compression systems. In terms of value, short stretch bandages are likely to dominate the market throughout the period of forecast, while the long stretch bandages segment is expected to be the fastest growing segment during 2022-2029.

Global Pressure Bandages Market: Forecast by ApplicationSegmentation by application includes lymphedema, leg ulcers, deep vein thrombosis and others. The leg ulcers segment is expected to be the most lucrative market for pressure bandages, with an attractiveness index of 1.9, while lymphedema is expected to remain the least attractive in the global market in revenue terms over the forecast period.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-1966

Global Pressure Bandages Market: Forecast by Raw MaterialThe different segments by raw material include cotton, latex, polyester, and others. Cotton dominated the pressure bandages market in revenue terms in 2021, and the trend is projected to continue throughout the forecast period.

Global Pressure Bandages Market: Forecast by Distribution ChannelOn the basis of distribution channel, the global pressure bandages market is segmented into retail stores, online stores, hypermarkets & supermarkets, pharmacies and clinics. Retail stores and online pharmacies segments are expected to reflect an attractiveness index of 1.8 over the forecast period. The retail stores segment accounted for a market share of 41.4% in 2021.

Global Pressure Bandages Market: Forecast by RegionThe seven key geographies of North America, Latin America, Eastern Europe, Western Europe, APEJ, Japan and MEA have been covered in this report. North America dominated the pressure bandages market in revenue terms in 2016, and the trend is projected to continue throughout the forecast period. MEA and Japan are expected to remain least attractive in the global market in revenue terms, with a market attractiveness index of 0.2 over the forecast period.

Global Pressure Bandages Market: Key PlayersSome of the key players in the global pressure bandages market profiled in the report are BSN Medical (Svenska Cellulosa Aktiebolaget SCA), Smith & Nephew, 3M Inc., Medtronic Plc., Cardinal Health and ConvaTec Inc.

Pressure bandages Market by CategoryBy Product Type:

  • Short Stretch Bandages
  • Long Stretch Bandages
  • Multi-layer Compression Systems

By Raw Material:

  • Cotton
  • Latex
  • Polyester

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-1966

By Application:

  • Lymphedema
  • Leg Ulcers
  • Deep Vein Thrombosis

By Distribution Channel:

  • Retail Stores
  • Online Stores
  • Hypermarkets and Supermarkets
  • Pharmacies
  • Clinics